BioCryst Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

BCRX 12.54 +0.02 (0.16%)
price chart
Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum ...
Although BioCryst Pharmaceuticals Inc.'s shares have declined 2.17% in the last three trading sessions, it has surged 35.37% in the previous three months and 48.55% on YTD basis.
Related articles »  
Use Options For a Chance To Buy BioCryst Pharmaceuticals at a 65% Discount
Looking back to 61 days ago, BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc. (NASD: BCRX) priced a $100,000,000 secondary stock offering at $10.00 per share.
Related articles »  
Market Movers : Delta Air Lines Inc. (NYSE:DAL), BioCryst Pharmaceuticals ...
On JULY 22, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced that its second quarter 2014 financial results will be released on Tuesday, August 5, 2014.
BioCryst Pharmaceuticals Short Interest Up 39.9% in July (BCRX)
BioCryst Pharmaceuticals logo BioCryst Pharmaceuticals (NASDAQ:BCRX) was the target of a large increase in short interest in the month of July.
BioCryst Pharmaceuticals Sees Large Increase in Short Interest (BCRX)  Ticker Report
Related articles »  
Stocks Roundup - Angie's List Inc (NASDAQ:ANGI), BioCryst Pharmaceuticals ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) released that its second quarter 2014 financial outcome will be declared on Tuesday, August 5, 2014.
BioCryst Pharmaceuticals Given Average Rating of "Buy" by Analysts (NASDAQ ...
BioCryst Pharmaceuticals logo BioCryst Pharmaceuticals (NASDAQ:BCRX) has earned a consensus rating of �Buy� from the twelve ratings firms that are currently covering the company, Analyst RN reports. Two analysts have rated the stock with a hold ...
Eye Catching Stocks: BioCryst Pharmaceuticals (NASDAQ:BCRX), M/A-Com ...
On 24 JULY BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) said that shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) were the target of a large growth in short interest in July.
News Buzz - Capstead Mortgage Corporation (CMO), BioCryst Pharmaceuticals ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
Related articles »  
Momentum Stocks in Focus - BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX ...
Las Vegas, NV - July 09, 2014 - (TechSonian )- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases ...
Related articles »  
BioCryst Pharmaceuticals Given Consensus Recommendation of "Buy" by ...
In other BioCryst Pharmaceuticals news, CFO Thomas R. Staab II sold 3,125 shares of the company's stock in a transaction that occurred on Tuesday, July 1st.